0001179110-19-005746.txt : 20190508
0001179110-19-005746.hdr.sgml : 20190508
20190508202228
ACCESSION NUMBER: 0001179110-19-005746
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190507
FILED AS OF DATE: 20190508
DATE AS OF CHANGE: 20190508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knowlton Calvin H
CENTRAL INDEX KEY: 0001685833
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37888
FILM NUMBER: 19808441
MAIL ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tabula Rasa HealthCare, Inc.
CENTRAL INDEX KEY: 0001651561
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 465726437
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
BUSINESS PHONE: 866-648-2767
MAIL ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
4
1
edgar.xml
FORM 4 -
X0306
4
2019-05-07
0
0001651561
Tabula Rasa HealthCare, Inc.
TRHC
0001685833
Knowlton Calvin H
228 STRAWBRIDGE DRIVE
SUITE 100
MOORESTOWN
NJ
08057
1
1
0
0
Chief Executive Officer
Common Stock
2019-05-07
4
S
0
3741
52.94
D
900834
D
Common Stock
2019-05-07
4
S
0
3529
54.09
D
897575
D
Common Stock
2019-05-07
4
S
0
1000
55.00
D
896575
D
Common Stock
807917
I
Held by spouse.
Common Stock
10000
I
Held by trust for children.
Common Stock
10000
I
Held by trust for children.
This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $52.42 to $53.31, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $53.58 to $54.56, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $54.81 to $55.53, inclusive.
The reporting person received a restricted stock award of 337,307 shares of the Company's common stock on September 28, 2016. Pursuant to amendments to the restricted stock award on June 12, 2017 and May 30, 2018, respectively, 50% of such shares of common stock were scheduled to vest on May 31, 2019, with the remaining 50% of such shares of common stock scheduled to vest on January 31, 2020. Notwithstanding the foregoing, on May 2, 2019, the Company entered into an amendment to the restricted stock award with the reporting person and, pursuant thereto, all shares of common stock underlying such restricted stock award will now vest in six equal installments at the end of each calendar quarter beginning on June 30, 2019 and ending on September 30, 2020, such that the shares of common stock underlying such restricted stock award will be vested in full on September 30, 2020.
/s/ Brian W. Adams, by Power of Attorney
2019-05-08